(Q38504789)

3 September 2017

title

Global gene expression profiling in early-stage polycystic kidney disease in the Han:SPRD Cy rat identifies a role for RXR signaling (English)

1 reference

polycystic kidney disease

3 September 2017

main subject

1 reference

10

Hiroki Kurahashi

1 reference

3 September 2017

Masanori Kugita

1

1 reference

3 September 2017

Kazuhiro Nishii

2

1 reference

3 September 2017

Miwa Morita

3

1 reference

3 September 2017

Daisuke Yoshihara

4

1 reference

3 September 2017

Hiroe Kowa-Sugiyama

5

1 reference

3 September 2017

Kouji Yamada

6

1 reference

3 September 2017

Tamio Yamaguchi

7

1 reference

3 September 2017

Darren P Wallace

8

1 reference

3 September 2017

James P Calvet

9

1 reference

3 September 2017

Shizuko Nagao

11

1 reference

3 September 2017

publication date

6 October 2010

1 reference

American Journal of Physiology - Renal Physiology

3 September 2017

published in

1 reference

3 September 2017

volume

300

1 reference

3 September 2017

issue

1

1 reference

3 September 2017

page(s)

F177-88

1 reference

Missense mutation in sterile alpha motif of novel protein SamCystin is associated with polycystic kidney disease in (cy/+) rat.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Methylprednisolone retards the progression of inherited polycystic kidney disease in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Genetics and pathogenesis of polycystic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Retinoic acid-dependent activation of the polycystic kidney disease-1 (PKD1) promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Epigenetic inactivation of retinoid X receptor genes in non-small cell lung cancer and the relationship with clinicopathologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Human renal mesangial cells are a target for the anti-inflammatory action of 9-cis retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

The effect of paclitaxel on the progression of polycystic kidney disease in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Overexpression of innate immune response genes in a model of recessive polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy/+ rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Androgen receptor pathway in rats with autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Nuclear receptors as potential targets for modulating reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Clinical profile of autosomal dominant polycystic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Sirolimus reduces polycystic liver volume in ADPKD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Role of FXR in regulating bile acid homeostasis and relevance for human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

15-Lipoxygenase-2 is differentially expressed in normal and neoplastic ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Wnt signaling regulates pancreatic beta cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Characterization of the Han:SPRD rat model for hereditary polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Interaction, cooperative promoter modulation, and renal colocalization of GCMa and Pitx2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

15-lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Vitamin E, nuclear receptors and xenobiotic metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

The cytoplasmic C-terminal fragment of polycystin-1 regulates a Ca2+-permeable cation channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Activation of liver X receptors and retinoid X receptors induces growth arrest and apoptosis in insulin-secreting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Expression, roles, receptors, and regulation of osteopontin in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Molecular pathogenesis of autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

Loss of Polycystin-1 in Human Cyst-Lining Epithelia Leads to Ciliary Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00470.2010

10.1152/AJPRENAL.00470.2010

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference